Newspaper Publication of Standalone Audited Financial Result for the quarter and financial Year ended on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jenburkt Pharmaceuticals has submitted to BSE the newspaper clippings of its standalone audited financial results for the fourth quarter and full financial year ended 31st March 2025. The results were published in The Free Press Journal (English) and Navshakti (Marathi) on 21st May 2025. The Board of Directors had approved these audited results at their meeting held on 20th May 2025, chaired by Chairman & Managing Director Ashish U. Bhuta. The detailed financial results are available on the BSE website and the company's investor page. This filing is in compliance with SEBI Listing Regulations (Regulation 33 read with Regulation 47(1)).
This is a routine regulatory compliance filing and does not contain any new financial numbers itself — the actual Q4/FY25 results were filed separately on 20th May 2025. No direct impact on shareholders or stock price is expected from this announcement.